Search Results for: COMBINATION PRODUCTS Device Development for
Articles
NEEDLE-FREE INJECTION - Portal PRIME: A Digitally Controlled, Cloud-Integrated Jet Injection System May 30, 2017
Patrick Anquetil, PhD, and Gaspar Taroncher-Oldenburg, PhD, report on Portal PRIME, a needle-free and digitally controlled jet injection device that is breaking new ground for injectable drug delivery.
SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: A Rise in Biologics & Improved Technology Give Pharma Reasons to Consider Parenteral Delivery May 2, 2017
Contributor Cindy H. Dubin speaks with some of the leading companies in this market to find out about key trends, packaging advancements, safety improvements, and technology developments.
Vectura Group Launches Utibron Neohaler in the US April 10, 2017
Vectura Group plc recently announced that Sunovion Pharmaceuticals Inc. has launched Utibron Neohaler (indacaterol/glycopyrrolate) in the US. Sunovion entered into...SteadyMed Completes Clinical Validation Study of Trevyent Study; Confirms Performance of PatchPump Technology April 10, 2017
SteadyMed Ltd. recently announced the successful completion of a clinical study for its lead drug product candidate, Trevyent. Trevyent is...CELLULAR MICROENCAPSULATION - Cell Encapsulation for Drug Delivery & Disease Treatment April 3, 2017
Gerald W. Crabtree, PhD, indicates drug or treatment delivery that employs microencapsulation, one of many promising developments in the field of regenerative medicine, offers not only treatments but also potential cures for a wide variety of maladies.
SPECIAL FEATURE - Bioavailability & Solubility: New Approaches to Enhance Drug Performance February 27, 2017
Contributor Cindy H. Dubin highlights many of the latest techniques to enhance bioavailability and solubility, how to determine the right technique for your compound, and how some companies are realizing faster time to market as a result.
Terumo & Nemera Announce Validated Compatibility Between PLAJEX Polymer Prefillable Syringes & Safe'n'Sound January 26, 2017
To serve the needs of the pharmaceutical industry and users, Nemera and Terumo agreed to cooperate to confirm compatibility between...Terumo & Nemera Announce Validated Compatibility Between PLAJEX Polymer Prefillable Syringes & Safe'n'Sound January 26, 2017
To serve the needs of the pharmaceutical industry and users, Nemera and Terumo agreed to cooperate to confirm compatibility between...SPECIAL FEATURE - Analytical Testing: Market Drivers, Growing Demand & Client Needs January 17, 2017
Contributor Cindy H. Dubin spoke with several testing providers to find out what services they offer, trends they identify, and how they have specifically addressed clients’ needs throughout the past year.
Impel NeuroPharma Announces $36-Million Funding to Advance Novel Delivery Platform December 12, 2016
Impel NeuroPharma, Inc. recently announced that it has closed a Series C funding round in an amount up to $36...SPECIAL FEATURE - Platform Technologies: Not Just for Big Pharma October 3, 2016
Contributor Cindy H. Dubin recently spoke with several companies that are debunking the theory that access to the latest technological platforms to aid efficient drug discovery and development is limited to Big Pharma, which can more easily justify the costs of creating and operating innovative platforms.
Phillips-Medsize to be Acquired by Molex August 23, 2016
Phillips-Medisize Corporation recently announced it has entered into a binding agreement to be acquired by Molex LLC, a global manufacturer...ICON to Acquire Clinical Research Management July 11, 2016
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries, recently...INDUSTRY PERSPECTIVES - What Surprised You the Most This Past Year?: Your Colleague’s Perspectives June 30, 2016
The Global Formulation Report in this issue provided some interesting data on what has been happening in a number of key sectors over the past year. We thought it would be intriguing to hear what some of your colleagues said surprised them most.
GLOBAL FORMULATION REPORT - Notable Technologies, Approvals, Transactions, Pipelines & Inflection Points June 30, 2016
This Global Formulation Report is a joint initiative by Drug Development & Delivery and PharmaCircle LLC, covering several areas of significant interest in today’s ever-challenging pharmaceutical and biotechnology industries.
ERT Develops Industry’s First Integration of Continuous Glucose Monitoring Data & eCOA June 27, 2016
ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, recently announced a data...SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing: Biologics Present a New Set of Challenges May 2, 2016
Contributor Cindy H. Dubin speaks with leading syringe developers and contract manufacturers to discuss how they are overcoming industry challenges and provides a look at some of the innovative advancements in prefilled syringe technology.
DRUG DELIVERY - PLEX(TM) Local Drug Delivery Platform Enables Prolonged, Controlled-Release Medications March 29, 2016
Noam Emanuel, PhD, reviews how PLEX is a unique local drug delivery platform that brings numerous innovative solutions to the market in various fields, such as infections, inflammations, and cancer.
DISSOLUTION TESTING - Exploring the Link Between Particle Size & Dissolution Behavior for OINDPs March 1, 2016
Paul Kippax, PhD; Deborah Huck-Jones, PhD; et al review current trends in dissolution testing within the context of understanding particle size, which impacts clinical studies and ultimately generic submissions.
SPECIAL FEATURE - Advancements in Drug Delivery Technologies Tackle Solubility & Bioavailability Challenges February 29, 2016
Contributor Cindy H. Dubin speaks with several innovator companies to learn more about the latest advances in drug delivery to address the challenging issues of solubility and bioavailability today
WHITEPAPER - Addressing Regulatory Challenges for Ophthalmic Combination Products
Going forward, sponsors developing ophthalmic products formulated for delivery as eye drops must be prepared to pursue development programs that address the regulatory requirements for drug-device combination products. Partnering with a contract manufacturing organization (CMO) that has experience bringing such products to market is essential…..
